Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| §112 only | 2 (33%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CELESTINE, NYROBI I | 1 | 81.4% | +23.1% |
| BURKHART, MICHAEL D | 1 | 62.2% | +11.5% |
| BOWLES, DAVID PAUL | 1 | 68.6% | +27.4% |
| JOHANSEN, PETER N. | 1 | 59.1% | +23.9% |
| MCANANY, JOHN D | 1 | 67.2% | +43.5% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.6% | +41.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18875528 | Fluid Monitoring System | CELESTINE, NYROBI I | — |
| 18568921 | GRANZYME B DETECTION | BOWLES, DAVID PAUL | — |
| 18274306 | FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD | JOHANSEN, PETER N. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18875528 | Fluid Monitoring System | CELESTINE, NYROBI I | — |
| 18690014 | GENETIC RESISTANCE TO VIRAL DISEASE IN SALMONID FISH | BURKHART, MICHAEL D | — |
| 18568921 | GRANZYME B DETECTION | BOWLES, DAVID PAUL | — |
| 18274306 | FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD | JOHANSEN, PETER N. | — |
| 18010440 | ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE, PIOGLITAZONE OR ROSIGLITAZONE | MCANANY, JOHN D | — |
| 17638542 | PARASITIC NEMATODE VACCINE | OGUNBIYI, OLUWATOSIN A | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 1653 | 1 |
| 1644 | 1 |
| 1625 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18875528 | Fluid Monitoring System | CELESTINE, NYROBI I | — | §102§103§112 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18690014 | GENETIC RESISTANCE TO VIRAL DISEASE IN SALMONID FISH | BURKHART, MICHAEL D | 1638 | §112 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18568921 | GRANZYME B DETECTION | BOWLES, DAVID PAUL | 1653 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18274306 | FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD | JOHANSEN, PETER N. | 1644 | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18010440 | ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE, PIOGLITAZONE OR ROSIGLITAZONE | MCANANY, JOHN D | 1625 | §103 | Non-Final OA | — | Pending | Dec 14, 2022 |
| 17638542 | PARASITIC NEMATODE VACCINE | OGUNBIYI, OLUWATOSIN A | 1645 | §112 | Non-Final OA | — | Pending | Feb 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial